Pharmacotherapy and Intensive Treatment of Drug Abuse - 1

K

Kansas Board of Regents

Status and phase

Completed
Phase 2

Conditions

Substance-Related Disorders
Cocaine-Related Disorders

Treatments

Drug: Carbamazepine

Study type

Interventional

Funder types

Other
Other U.S. Federal agency
NIH

Identifiers

NCT00000217
NIDA-06954-1
R18-06954-1
R18DA006954 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of this study is to evaluate desipramine and carbamazepine in reducing cocaine craving; increase outpatient treatment capacity and evaluate their incidence of psychiatric disorders.

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems